Login to Your Account



Pharma: Other News To Note


Tuesday, June 4, 2013
• Renaissance Acquisition Holdings LLC, of Montreal, and GlaxoSmithKline plc, of London, entered an agreement giving Renaissance the rights in the U.S. to manufacture, market and sell six dermatology and three antiviral products from GSK.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription